Advanced Search

Home > Journals > Otorinolaringologia > Past Issues > Otorinolaringologia 2012 June;62(2) > Otorinolaringologia 2012 June;62(2):101-19



A Journal on Otorhinolaryngology, Head and Neck Surgery,
Plastic Reconstructive Surgery, Otoneurosurgery

Indexed/Abstracted in: EMBASE, Scopus

Frequency: Quarterly

ISSN 0026-4938

Online ISSN 1827-188X


Otorinolaringologia 2012 June;62(2):101-19


Rational for immunotherapy treatment of otitis media with effusion

Hurst D. S.

Tufts University, Boston, MA, USA

This review will examine the science that supports or refutes the possible value of using immunotherapy for the treatment of chronic middle ear disease. The role of allergy in chronic otitis media with effusion (OME) is controversial. New evidence from the fields of cellular biology and immunology now explain the basics of allergic reactions, and allow us to more accurately diagnose allergies and understand the allergic contribution to chronic inflammatory disease throughout the unified airway, including the middle ear. This review will examine the epidemiologic, methodological and immunologic studies of allergic causes of OME, including: evidence for and against OME as an allergic disease 2) allergy as a cause for Eustachian tube (ET) obstruction 3) examination of the most sensitive diagnostic tests for allergy and 4) the evidence demonstrating that immunotherapy treatment of underlying allergies leads to resolution of chronic middle ear disease.

language: English


top of page